BLISTEX DCT 7.3 %
OCTINOXATE : 7.3 % MENTHOL : 0.6 % OXYBENZONE : 4.5 % CAMPHOR : 0.38 % PHENOL : 0.48 % · DIN 02157292 · BLISTEX CORPORATION
Health Canada status: MARKETED
What is BLISTEX DCT?
BLISTEX DCT 7.3 % contains OCTINOXATE : 7.3 % MENTHOL : 0.6 % OXYBENZONE : 4.5 % CAMPHOR : 0.38 % PHENOL : 0.48 %. It is listed in the Health Canada Drug Product Database under DIN 02157292, held by BLISTEX CORPORATION, supplied as OINTMENT for TOPICAL administration. Health Canada currently lists it as marketed, status dated 13-Feb-2014. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What else is BLISTEX DCT called?
The same molecule, COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Ekyflogyl | Latin | Iceland |
| OTIPAX | Latin | Czechia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02157292 |
|---|---|
| Brand name | BLISTEX DCT |
| Generic / active ingredient | OCTINOXATE : 7.3 % MENTHOL : 0.6 % OXYBENZONE : 4.5 % CAMPHOR : 0.38 % PHENOL : 0.48 % |
| Manufacturer | BLISTEX CORPORATION |
| Strength | 7.3 % |
| Dosage form | OINTMENT |
| Route of administration | TOPICAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | D02BA30 COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION |
| AHFS class | 84:80.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 13-Feb-2014 |
| Original market date | 1995-12-31 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02157292 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2157292 |
| Brand name | BLISTEX DCT |
| Active ingredient / INN | OCTINOXATE : 7.3 % MENTHOL : 0.6 % OXYBENZONE : 4.5 % CAMPHOR : 0.38 % PHENOL : 0.48 % |
| ATC code | D02BA30 |
| ATC anatomical main group | D — Dermatologicals |
| ATC therapeutic subgroup | D02 |
| AHFS class | 84:80.00 |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| Biosimilar biologic | No |
| Market authorization holder | BLISTEX CORPORATION |
Which pack is which?
| Strength on the label | 7.3 % |
|---|---|
| Dosage form | OINTMENT |
| Route | TOPICAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code D02BA30 COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION. 485 of 4952 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| 7 IN ONE TONE CORRECTING CC CREAM WITH SPF | 3 % | CREAM | PROCTER & GAMBLE INC | MARKETED | DIN 02514419 |
| ABSOLUTELY AGELESS DAILY MOISTURIZER | 4 % | LOTION | JOHNSON & JOHNSON INC | MARKETED | DIN 02440873 |
| ADAPTASUN SEA AND TROPICS PROTECTIVE BODY LOTION SPF 30 | 2.7 % | LOTION | NAOS CANADA INC. | MARKETED | DIN 02528029 |
| AGE DEFYING ANTI-WRINKLE LOTION WITH SPF | 3 % | LOTION | PROCTER & GAMBLE INC | MARKETED | DIN 02444208 |
| AGE DEFYING CLASSIC LOTION WITH SPF | 3 % | LOTION | PROCTER & GAMBLE INC | MARKETED | DIN 02460882 |
| ANEW PLATINUM DAY CREAM | 4.75 % | CREAM | THE AVON COMPANY CANADA LIMITED | MARKETED | DIN 02353873 |
| ANEW ULTIMATE MULTI-PERFORMANCE DAY CREAM CRÈME DE JOUR BROAD SPECTRUM SPF25 À LARGE SPECTRE FPS 25 | 4 % | CREAM | THE AVON COMPANY CANADA LIMITED | MARKETED | DIN 02431432 |
| ANTHELIOS 50+ | 10 % | LOTION | LABORATOIRES LA ROCHE-POSAY CANADA | MARKETED | DIN 02538938 |
| ANTHELIOS DERMO-KIDS 50+ | 5 % | CREAM | LABORATOIRES LA ROCHE-POSAY CANADA | MARKETED | DIN 02527766 |
| ANTI-AGING COMPLEX EMULSION BROAD SPECTRUM SPF 30 | 2.35 % | EMULSION | MERLE NORMAN COSMETICS INC | MARKETED | DIN 02399113 |
Who else supplies COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION appears in 5 registered pack listings across 2 markets, published on 2 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION cost around the world?
COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION is listed on 4 national price registers Nexara tracks, across 8 pack listings published on 4 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| Hungary | producer price (ex-factory) | 5 | 5 | 03 Sep 2026 |
| Czechia | max producer price (ex-factory) | 1 | 1 | 03 Sep 2026 |
| Iceland | max wholesale | 1 | 1 | 02 Sep 2026 |
| Luxembourg | reimbursement | 1 | 1 | 05 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.